V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20210710 | 20078382 | 0 | 0 | Palliative (P) | 2019-08-10 | 2019-08-21 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101457111 |
| 20210715 | 20078383 | 1.73 | 72.5 | Curative (C) | 2020-02-24 | 2020-02-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100312675 |
| 20210717 | 20078384 | 1.6 | 65.3 | Palliative (P) | 2016-06-06 | 2016-06-06 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101075756 |
| 20210719 | 20078385 | 1.74 | 61.4 | Palliative (P) | null | 2017-05-08 | Cisplatin +Fluorouracil (2 wk) | N | N | CISPLATIN + FLUOROURACIL | 100091593 |
| 20210722 | 20078386 | 1.66 | 74 | Palliative (P) | 2019-05-13 | 2019-05-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101048774 |
| 20210724 | 20078387 | 1.69 | 82.35 | null | 2005-07-27 | 2019-07-06 | CAPECITABINE + CARBOPLATIN | 2 | null | CAPECITABINE + CARBOPLATIN | 101843730 |
| 20210726 | 20078388 | null | 49.2 | Adjuvant (A) | 2019-10-17 | 2019-10-28 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 101046629 |
| 20210731 | 20078389 | 1.65 | 67.8 | Palliative (P) | 2018-08-13 | 2018-08-13 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100427964 |
| 20210733 | 20078390 | 1.7 | 68.8 | Curative (C) | 2016-05-04 | 2016-05-06 | Trial Unspecified | 02 | Y | TRIAL UNSPECIFIED | 101209619 |
| 20210736 | 20078391 | 1.47 | 55.15 | Curative (C) | 2020-12-16 | 2021-01-13 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101724426 |
| 20210737 | 20078392 | 1.74 | 78 | Adjuvant (A) | 2019-03-22 | 2019-03-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101648638 |
| 20210747 | 20078393 | 0 | 0 | Palliative (P) | 2021-03-29 | 2021-04-05 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100452409 |
| 20210748 | 20078394 | 0 | 0 | Palliative (P) | 2019-03-12 | 2019-03-27 | Doxorubicin chemoembolisation | N | N | DOXORUBICIN EMBOLISATION | 101744530 |
| 20210754 | 20078395 | null | null | Curative (C) | 2021-03-19 | 2021-04-14 | Doxorubicin chemoembolisation | 99 | Y | DOXORUBICIN EMBOLISATION | 100141247 |
| 20210757 | 20078396 | null | 85.2 | Palliative (P) | 2017-05-06 | 2017-05-14 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100658411 |
| 20210761 | 20078397 | 1.56 | 62.3 | Palliative (P) | 2016-10-03 | 2016-10-04 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101109328 |
| 20210762 | 20078398 | 1.5 | 64.2 | Neo-adjuvant (N) | 2017-03-11 | 2017-03-18 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101016908 |
| 20210769 | 20078399 | 1.8 | 82.15 | Palliative (P) | 2016-05-22 | 2016-05-22 | CAPECITABINE + CARBOPLATIN | N | N | CISPLATIN + FLUOROURACIL | 100790938 |
| 20210773 | 20078400 | 1.74 | 58 | null | 2016-07-06 | 2016-07-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100002737 |
| 20210774 | 20078401 | 1.7 | null | Palliative (P) | 2019-04-12 | 2019-04-12 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100410147 |
| 20210779 | 20078402 | 1.49 | 53.2 | Palliative (P) | 2018-06-01 | 2018-06-08 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101246204 |
| 20210782 | 20078403 | null | 65.7 | 03 | 2019-07-20 | 2019-07-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101092898 |
| 20210786 | 20078404 | 1.55 | 65.75 | Neo-adjuvant (N) | 2017-05-26 | 2017-06-15 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100365847 |
| 20210787 | 20078405 | 1.61 | 73 | Neo-adjuvant (N) | 2018-11-25 | 2018-12-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100180458 |
| 20210791 | 20078406 | 1.91 | 131 | null | 2018-06-25 | 2018-06-27 | Cisplatin + Fluorouracil + RT 5day | 02 | null | CISPLATIN + FLUOROURACIL | 100488500 |
| 20210792 | 20078407 | 1.58 | 135 | Palliative (P) | 2019-09-05 | 2019-09-15 | CAPECITABINE + CARBOPLATIN | N | N | TRIAL UNSPECIFIED | 100393674 |
| 20210795 | 20078408 | 1.62 | 80.75 | Curative (C) | 2017-09-15 | 2017-10-06 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100454939 |
| 20210796 | 20078409 | 1.87 | 56.4 | Palliative (P) | 2017-07-31 | 2017-08-10 | Trial Unspecified | null | Y | TRIAL UNSPECIFIED | 100562021 |
| 20210798 | 20078410 | 1.71 | 73.8 | Palliative (P) | 2020-01-03 | 2020-01-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100770177 |
| 20210800 | 20078411 | 1.64 | 49.6 | Palliative (P) | 2016-10-29 | 2017-02-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100506056 |
| 20210801 | 20078412 | 1.78 | 75 | Palliative (P) | 2017-11-27 | 2017-11-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100470138 |
| 20210806 | 20078413 | 1.56 | 57.7 | Neo-adjuvant (N) | 2020-05-10 | 2020-05-11 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100634991 |
| 20210811 | 20078414 | 1.64 | 61.6 | Palliative (P) | 2016-07-11 | 2016-07-15 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100362822 |
| 20210814 | 20078415 | 1.86 | 83.9 | Palliative (P) | 2018-07-28 | 2018-07-28 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100254617 |
| 20210821 | 20078416 | 1.62 | 82.4 | Palliative (P) | 2018-04-07 | 2018-04-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101226094 |
| 20210822 | 20078417 | 1.54 | 59 | Palliative (P) | 2016-10-10 | 2016-10-17 | CISPLATIN + FLUOROURACIL | N | Y | CISPLATIN + FLUOROURACIL | 101733488 |
| 20210823 | 20078418 | 1.52 | 106 | Palliative (P) | 2018-07-02 | 2018-08-12 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101782271 |
| 20210827 | 20078419 | 1.73 | 67.8 | Palliative (P) | 2018-04-24 | 2018-05-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101519295 |
| 20210830 | 20078420 | 1.87 | 95.4 | null | 2018-09-19 | 2018-09-21 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101709402 |
| 20210833 | 20078421 | 1.78 | 79.3 | Neo-adjuvant (N) | 2018-09-05 | 2018-09-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100698632 |
| 20210837 | 20078422 | 1.71 | 69.4 | Neo-adjuvant (N) | 2019-09-02 | 2019-09-18 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100817463 |
| 20210842 | 20078423 | 1.66 | 78 | Curative (C) | 2018-01-10 | 2018-03-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101157678 |
| 20210843 | 20078424 | 0 | 0 | null | 2019-08-14 | 2019-08-30 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101780499 |
| 20210850 | 20078425 | 1.74 | 57 | Palliative (P) | 2019-12-08 | 2019-12-22 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 101769816 |
| 20210851 | 20078426 | 1.6 | 64.75 | Palliative (P) | 2018-03-12 | 2018-03-12 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100296532 |
| 20210852 | 20078427 | 1.73 | 50.2 | Palliative (P) | 2018-03-26 | 2018-04-09 | CAPECITABINE + CARBOPLATIN | 02 | N | CISPLATIN + FLUOROURACIL | 100429287 |
| 20210857 | 20078428 | 1.63 | 14.5 | null | 2018-03-18 | 2018-04-02 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100623249 |
| 20210862 | 20078429 | 1.78 | 59.7 | Neo-adjuvant (N) | 2016-02-20 | 2016-03-05 | Trial Unspecified | null | N | TRIAL UNSPECIFIED | 101524544 |
| 20210863 | 20078430 | 1.63 | 86 | Palliative (P) | 2016-12-14 | 2016-12-26 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101494669 |
| 20210868 | 20078431 | 1.67 | 46.9 | Palliative (P) | 2017-03-23 | 2017-04-10 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 101553044 |